HCW Biologics Inc.HCWB
...Loading HCWB Peers...
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
45 Employees
CEO : Dr. Hing C. Wong Ph.D.
Address : 2929 North Commerce Parkway, Miramar,FL, US, - 33025,
| Key Excutives | Designation |
|---|---|
| Dr. Hing C. Wong Ph.D. | Founder, Chief Executive Officer, Director & Secretary |
| Mr. Lee D. Flowers | Senior Vice President of Business Development |
| Ms. Rebecca Byam CPA, M.B.A. | Chief Financial Officer |
| Dr. Peter Rhode Ph.D. | Chief Scientific Officer & Vice President of Clinical Operations |
| Ms. Nicole Valdivieso Esq. | Vice President of Legal Affairs |